• 아스트라 제네카와 옥스포드 대학에서 개발된 백신은 70 %의 사람들이 후기 시험에서 코로나 바이러스 발병을 막았다고 팀은 11 월 월요일에 보고했습니다.


Login to comment
Open Wiki
- Feel free to edit it. -
11/26 '20
answered
An accident in AstraZeneca's trial is leading the company to seek a change in its US trial to pursue a 90% efficacious vaccine.
— Anjalee Khemlani (@AnjKhem) November 24, 2020
A quick breakdown of what we learned yesterday, what to expect going forward. $AZNhttps://t.co/KJK0fRyM93
Super proud of our team.. AstraZeneca has the least vaccine experience of the front-runners racing to deliver a Covid-19 shot. But it has promised the world the most doses. https://t.co/TRFhDzN4qE
— Menelas Pangalos (@MenePangalos) November 24, 2020
"AstraZeneca plans to supply every region of the world by 2022 without profiting directly from the vaccine during the pandemic. Working in partnership with the University of Oxford, the company is pricing the vaccine at $3 to $5 a dose."https://t.co/2dir72bdWx?
— Aisehman | Darurat = Mudarat (@Aisehman) November 24, 2020
Login to comment